Reuters logo
BRIEF-Alnylam says ‍inclisiran phase III development program gearing up​
August 28, 2017 / 12:47 PM / 24 days ago

BRIEF-Alnylam says ‍inclisiran phase III development program gearing up​

Aug 28 (Reuters) - Alnylam Pharmaceuticals Inc

* New, one-year data from orion-1 phase ii study of inclisiran extends excellent long-term efficacy and safety profile, affirming dose for phase iii trials

* Alnylam pharmaceuticals inc - ‍inclisiran phase iii development program gearing up​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below